| Trial ID: | L4837 |
| Source ID: | NCT00422955
|
| Associated Drug: |
Rosiglitazone
|
| Title: |
Fluid Retention in Rosiglitazone Treated Subjects With Autonomic Neuropathy.
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Neuropathy, Diabetic
|
| Interventions: |
DRUG: rosiglitazone
|
| Outcome Measures: |
Primary: Change in transcapillary escape rate of L125 albumin following 16 weeks treatment | Secondary: Change in plasma volume, pedal oedema, extracellular fluid volume following 16 weeks treatment.
|
| Sponsor/Collaborators: |
Sponsor: GlaxoSmithKline
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE3
|
| Enrollment: |
36
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2003-11
|
| Completion Date: |
2005-10
|
| Results First Posted: |
|
| Last Update Posted: |
2016-09-15
|
| Locations: |
GSK Investigational Site, Nijmegen, 6525 EZ, Netherlands
|
| URL: |
https://clinicaltrials.gov/show/NCT00422955
|
